Furosemide 40mg/4mL Injection

Furosemide 40mg/4mL Injection is an injectable loop diuretic used in supervised care when rapid or reliable fluid removal is needed or when oral furosemide is not practical. Furosemide increases urine output by blocking salt reabsorption in the loop of Henle. It is not a general swelling treatment without diagnosis.
Furosemide 40mg/4mL Injection is given by IV or IM route by healthcare professionals. Dose and speed are individualized. Monitoring includes urine output, blood pressure, electrolytes, kidney function, and signs of over-diuresis or hearing symptoms.
Furosemide inhibits the sodium-potassium-chloride cotransporter in the thick ascending loop of Henle, causing salt and water loss in urine.
Possible effects include increased urination, dizziness, low blood pressure, thirst, cramps, nausea, headache, and injection-site discomfort. Serious risks include dehydration, kidney injury, severe electrolyte imbalance, hearing loss or ringing, allergic reaction, and gout flare.
Tell the clinician about kidney disease, liver disease, gout, diabetes, low blood pressure, dehydration, hearing problems, pregnancy, breastfeeding, aminoglycosides, lithium, digoxin, NSAIDs, ACE inhibitors, ARBs, and other diuretics.
Supervised treatment of edema or fluid overload for injectable furosemide treatment.
Provides rapid, controllable diuretic effect when oral therapy cannot be used or urgent fluid removal is needed.
Furosemide 40mg/4mL Injection is used to remove excess fluid in supervised settings for injectable furosemide treatment.
Rapid fluid and electrolyte changes can affect blood pressure, kidney function, heart rhythm, and hearing.
Rarely, especially with rapid IV dosing, high doses, kidney impairment, or other ototoxic medicines.
Severe thirst, dizziness, fainting, confusion, very low urine after dosing, or muscle cramps need review.
Only after the cause of swelling is assessed and injectable treatment is considered necessary.
Furosemide, IV loop diuretic, Edema, Fluid overload treatment, Electrolyte monitoring, Ototoxicity warning, AR: Furosemide / حقن, FR: Furosemide /, PT: Furosemide / injeção, ES: Furosemide / inyección, RU: Furosemide / инъекция, ID: Furosemide / injeksi, VI: Furosemide / thuốc tiêm, MS: Furosemide / suntikan, TL: Furosemide / iniksyon, ZH-SG: Furosemide / 注射剂
International B2B Enquiry
Send a structured B2B enquiry for Furosemide 40mg/4mL Injection under Cardiac Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Furosemide 40mg/4mL Injection